The general objective of the iPAAC Joint Action (JA) is to develop innovative approaches to advances in cancer control. The innovation that will be covered within the JA consists of further development of cancer prevention, comprehensive approaches to the use of genomics in cancer control, cancer information and registries, improvements and challenges in cancer care, mapping of innovative cancer treatments and governance of integrated cancer control, including a new analysis of National Cancer Control Plans. The key focus of the Joint Action will be on implementation, as reflected in the key deliverable, i.e. the Roadmap on Implementation and Sustainability of Cancer Control Actions, which will support member states in the implementation of iPAAC and CANCON recommendations.
million EUR co-funding by EC
44 partners (Competent Authorities and Affiliated Entities)
12 Mar 2020
The third WP5 conference on cancer prevention and health promotion
The iPAAC WP5 conference will be changing its structure. The planned Lyon meeting in April is postponed to Autumn 2020.
27 Feb 2020
Europe’s Beating Cancer Plan public consultation
The consultation is addressed to individual citizens, patients, and carers replying in their personal capacity as well as health professionals and organisations involved in cancer prevention, diagnosis, treatment, follow-up care and research.
07 Feb 2020
Results of the Contest of Best Practices tackling social inequalities in cancer prevention
iPAAC partner FISABIO (Fundació per al Foment de la Investigació Sanitaria I Biomèdica de la Comunitat Valenciana) launched in 2019 a Contest of Best Practices tackling social inequalities in cancer prevention, including both health promotion and cancer screening programmes.
04 Feb 2020
Future Europe's Beating Cancer Plan supported by the activities of Joint Actions Against Cancer (EPAAC, CANCON, iPAAC)
Tackling cancer is one of the von der Leyen Commission’s main priorities in the area of health, since data shows that the number of cancer cases in the EU will double by 2035.